PVLA
Palvella Therapeutics
PVLA
PVLA
82 hedge funds and large institutions have $83.6M invested in Palvella Therapeutics in 2020 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
38% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 16
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $56K
Holders
82
Holding in Top 10
–
Calls
–
Puts
$56K
Top Buyers
| 1 | +$1.77M | |
| 2 | +$1.38M | |
| 3 | +$433K | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$382K |
| 5 |
BlackRock
New York
|
+$169K |
Top Sellers
| 1 | -$952K | |
| 2 | -$589K | |
| 3 | -$459K | |
| 4 |
Cerity Partners
New York
|
-$453K |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$300K |